P-type calcium channel
This article may be too technical for most readers to understand.(January 2016) |
The P-type calcium channel is a type of
History
The calcium channel experiments that led to the discovery of P-type calcium channels were initially completed by
Basic features and structure
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Symbol | CACNA1A | ||||||
Alt. symbols | Chr. 19 p13 | ||||||
|
P-type calcium channels are
Voltage-gated P-type calcium channels consist of a main pore-forming α1 subunit (which is more specifically referred to as
Channel distribution
Areas of high expression in mammalian systems include:
- Purkinje cell dendrites[8]
- Smooth endoplasmic reticulum
- Cell membrane
- Periglomerular cells in the olfactory bulb
- Cerebellar cortex
- Neurons in the brainstem, entorhinal and piriform cortices, and the habenula.[7]
Channel blockers
P-type calcium channel blockers act to impede the flow of calcium. The blocking of calcium currents may cause the organism to experience impaired functioning and viability. These effects can lead to various diseases which are described in more detail in the section below.
The pore of P-type calcium channels are sensitive to compounds that can be divided into three groups:
- Peptide ion channel blockers
- Low molecular weight compounds
- Therapeutics[1]
There are only two peptide toxins that selectively block P-type channels: ω-agatoxin IVA and ω-agatoxin IVB. The other blockers mentioned, such as the low molecular weight and therapeutic blockers, are nonselective. This means they act can act on P-type channels as well as other channels.[1]
Selective peptide toxin ω-agatoxin
The two known blockers which are specific to P-type calcium channels are peptides derived from the spider venom of
Non-selective peptide toxins
- Grammostola spatulata. It acts to modify the P-type channel gating.
- ω-PnTx3-3, PnTx3-3, and phonetoxin IIA are all toxins from the spider Phonoetrica nigriventer which act to block the current through the P-type calcium channels.
- DW13.3 is a peptide toxin from the spider Filistata hibernalis and it is composed of 74 amino acids. It also functions to block the current through P-type calcium channels.
- ω-pyramidal neurons to block the P-type channels. Also, within the hippocampal CA3 neurons, this toxin blocks synaptic transmission. Its effects are slow.
- Calcicludine is from venom of Dendroaspis angusticeps, which is a green mamba. It has the ability to voltage-dependently block P-type channels.
- Kurotoxin is from venom of the scorpion Parabuthus. In neurons in the thalamus, kurtoxin decreases high threshold calcium currents, however, in the Purkinje cells, it increases the calcium currents.[1]
Low molecular weight P-type channel blockers
Low molecular weight channel blockers have advantages over peptide blockers in drug development. One advantage of low molecular weight channel blockers is that they can penetrate tissue, which is important for crossing the blood–brain barrier. There is no specific low molecular weight channel blocker for P-type channels. However, there are a number of these blocker compounds which can effect the activity of the P-type channels.[1] These include:
- neostriatal interneurons by slowing the deactivation of the channel. Also, roscovitine can either act as an agonist or antagonistfor the P-type calcium channels in the presynaptic membrane.
- Isoprenaline is a β-adrenoceptor agonist and it causes an increase in P-type calcium channel current. Isoprenaline acts through a cAMP signaling pathway.
- NMDA receptor antagonists and act to block P-type channels. Eliprodil can decrease P-type channel currents in the Purkinje neurons in the cerebellum.
- Dodecylamine can only block P-type channels when they are in the open state.
- Ethanol can block P-type channels when at a high enough concentration. The blocking of the P-type channels could be the reason for ataxia when drinking alcohol.[1]
Therapeutics
There are therapeutics used clinically which can effect the activity of P-type calcium channels. However, the primary
Related diseases
There are a number of neurological diseases that have been attributed to malfunctioning or mutated P/Q type channels.[6]
Alzheimer's disease
In
Migraine headaches
The
Seizures
Mutation studies
Many P-type calcium channels mutations result in a decreased level of intracellular free calcium. Maintaining calcium homeostasis is essential for normally functioning neurons. Changing the cellular calcium ion concentration acts as a trigger for multiple diseases, in severe cases these diseases can result in mass neuronal death.[6]
Mutation studies allow experimenters to study genetically inherited channelopathies. A channelopathy is any disease that results from an ion channel with malfunctioning subunits or regulatory proteins.[6] One example of a P-type calcium channel channelopathy is shown in homozygous ataxic mice, who are recessive for both the tottering and leaner genes. These mice present with mutations in the alpha1A subunit of their P/Q type channels. Mutations in these channels result in deficiencies within the cerebellar Purkinje cells that dramatically reduce the channels current density.[6]
The tottering mutations within mice result from a
See also
- Cav2.1
- voltage-dependent calcium channel